The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway

被引:477
作者
Nijman, SMB
Huang, TT
Dirac, AMG
Brummelkamp, TR
Kerkhoven, RM
D'Andrea, AD
Bernards, R
机构
[1] Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
关键词
D O I
10.1016/j.molcel.2005.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein ubiquitination and deubiquitination are dynamic processes implicated in the regulation of numerous cellular pathways. Monoubiquitination of the Fanconi anemia (FA) protein FANCD2 appears to be critical in the repair of DNA damage because many of the proteins that are mutated in FA are required for FANCD2 ubiquitination. By screening a gene family RNAi library, we identify the deubiquitinating enzyme USP1 as a novel component of the Fanconi anemia pathway. Inhibition of USP1 leads to hyperaccumulation of monoubiquitinated FANCD2. Furthermore, USP1 physically associates with FANCD2, and the proteins colocalize in chromatin after DNA damage. Finally, analysis of crosslinker-induced chromosomal aberrations in USP1 knockdown cells suggests a role in DNA repair. We propose that USP1 deubiquitinates FANCD2 when cells exit S phase or recommence cycling after a DNA damage insult and may play a critical role in the FA pathway by recycling FANCD2.
引用
收藏
页码:331 / 339
页数:9
相关论文
共 39 条
[31]   Multiple roles of Rev3, the catalytic subunit of pole in maintaining genome stability in vertebrates [J].
Sonoda, E ;
Okada, T ;
Zhaol, GY ;
Tateishi, S ;
Araki, K ;
Yarnaizumi, M ;
Yagi, T ;
Verkaik, NS ;
van Gent, DC ;
Takata, M ;
Takeda, S .
EMBO JOURNAL, 2003, 22 (12) :3188-3197
[32]   S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51 [J].
Taniguchi, T ;
Garcia-Higuera, I ;
Andreassen, PR ;
Gregory, RC ;
Grompe, M ;
D'Andrea, AD .
BLOOD, 2002, 100 (07) :2414-2420
[33]   Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors [J].
Taniguchi, T ;
Tischkowitz, M ;
Ameziane, N ;
Hodgson, SV ;
Mathew, CG ;
Joenje, H ;
Mok, SC ;
D'Andrea, AD .
NATURE MEDICINE, 2003, 9 (05) :568-574
[34]   Convergence of the Fanconi anemia and ataxia telangiectasia signaling pathways [J].
Taniguchi, T ;
Garcia-Higuera, I ;
Xu, B ;
Andreassen, PR ;
Gregory, RC ;
Kim, ST ;
Lane, WS ;
Kastan, MB ;
D'Andrea, AD .
CELL, 2002, 109 (04) :459-472
[35]   Bi-allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia [J].
Tischkowitz, M ;
Ameziane, N ;
Waisfisz, Q ;
De Winter, JP ;
Harris, R ;
Taniguchi, T ;
D'Andrea, A ;
Hodgson, SV ;
Mathew, CG ;
Joenje, H .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) :469-471
[36]   CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members [J].
Trompouki, E ;
Hatzivassiliou, E ;
Tsichritzis, T ;
Farmer, H ;
Ashworth, A ;
Mosialos, G .
NATURE, 2003, 424 (6950) :793-796
[37]   Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin [J].
Wang, XZ ;
Andreassen, PR ;
D'Andrea, AD .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) :5850-5862
[38]   Identification of genes periodically expressed in the human cell cycle and their expression in tumors [J].
Whitfield, ML ;
Sherlock, G ;
Saldanha, AJ ;
Murray, JI ;
Ball, CA ;
Alexander, KE ;
Matese, JC ;
Perou, CM ;
Hurt, MM ;
Brown, PO ;
Botstein, D .
MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (06) :1977-2000
[39]   Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome [J].
Wilkinson, KD .
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2000, 11 (03) :141-148